Rufinamide tablets are indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older, and in adults.
Retatrutide, an investigational molecule being studied for the treatment of obesity, met the primary endpoint for the efficacy estimand in participants.
Michael Ganio, senior director of pharmacy practice and quality at The American Society of Health-System Pharmacists, highlights current shortages of medications in certain therapeutic categories.